nodes	percent_of_prediction	percent_of_DWPC	metapath
Gonadorelin—Developmental delay—Leflunomide—systemic scleroderma	0.031	0.031	CcSEcCtD
Gonadorelin—Congenital anomaly—Leflunomide—systemic scleroderma	0.031	0.031	CcSEcCtD
Gonadorelin—Congenital anomaly—Mycophenolic acid—systemic scleroderma	0.0296	0.0296	CcSEcCtD
Gonadorelin—Developmental delay—Mycophenolic acid—systemic scleroderma	0.0296	0.0296	CcSEcCtD
Gonadorelin—Congenital anomaly—Mycophenolate mofetil—systemic scleroderma	0.0233	0.0233	CcSEcCtD
Gonadorelin—Developmental delay—Mycophenolate mofetil—systemic scleroderma	0.0233	0.0233	CcSEcCtD
Gonadorelin—Pelvic pain—Leflunomide—systemic scleroderma	0.0194	0.0194	CcSEcCtD
Gonadorelin—Thromboembolism—Prednisone—systemic scleroderma	0.0189	0.0189	CcSEcCtD
Gonadorelin—Haematoma—Leflunomide—systemic scleroderma	0.0187	0.0187	CcSEcCtD
Gonadorelin—Contusion—Mometasone—systemic scleroderma	0.0186	0.0186	CcSEcCtD
Gonadorelin—Pelvic pain—Mycophenolic acid—systemic scleroderma	0.0185	0.0185	CcSEcCtD
Gonadorelin—Dysmenorrhoea—Mometasone—systemic scleroderma	0.0179	0.0179	CcSEcCtD
Gonadorelin—Pelvic pain—Lisinopril—systemic scleroderma	0.0166	0.0166	CcSEcCtD
Gonadorelin—Swelling—Pentoxifylline—systemic scleroderma	0.0155	0.0155	CcSEcCtD
Gonadorelin—Pelvic pain—Mycophenolate mofetil—systemic scleroderma	0.0146	0.0146	CcSEcCtD
Gonadorelin—Contusion—Leflunomide—systemic scleroderma	0.0135	0.0135	CcSEcCtD
Gonadorelin—Contusion—Mycophenolic acid—systemic scleroderma	0.0129	0.0129	CcSEcCtD
Gonadorelin—Embolism venous—Prednisone—systemic scleroderma	0.0119	0.0119	CcSEcCtD
Gonadorelin—Breast pain—Lisinopril—systemic scleroderma	0.0116	0.0116	CcSEcCtD
Gonadorelin—Abdominal discomfort—Pentoxifylline—systemic scleroderma	0.0113	0.0113	CcSEcCtD
Gonadorelin—Breast pain—Mycophenolate mofetil—systemic scleroderma	0.0102	0.0102	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Mometasone—systemic scleroderma	0.00949	0.00949	CcSEcCtD
Gonadorelin—Embolism—Prednisone—systemic scleroderma	0.00936	0.00936	CcSEcCtD
Gonadorelin—Swelling—Mycophenolic acid—systemic scleroderma	0.00924	0.00924	CcSEcCtD
Gonadorelin—Injection site reaction—Mycophenolate mofetil—systemic scleroderma	0.00881	0.00881	CcSEcCtD
Gonadorelin—Immune system disorder—Pentoxifylline—systemic scleroderma	0.00855	0.00855	CcSEcCtD
Gonadorelin—Erythema—Pentoxifylline—systemic scleroderma	0.00824	0.00824	CcSEcCtD
Gonadorelin—Flatulence—Pentoxifylline—systemic scleroderma	0.00812	0.00812	CcSEcCtD
Gonadorelin—Embolism—Methotrexate—systemic scleroderma	0.00782	0.00782	CcSEcCtD
Gonadorelin—Breast disorder—Leflunomide—systemic scleroderma	0.00773	0.00773	CcSEcCtD
Gonadorelin—Abdominal discomfort—Azathioprine—systemic scleroderma	0.0075	0.0075	CcSEcCtD
Gonadorelin—Immune system disorder—Mometasone—systemic scleroderma	0.00738	0.00738	CcSEcCtD
Gonadorelin—Breast disorder—Mycophenolic acid—systemic scleroderma	0.00737	0.00737	CcSEcCtD
Gonadorelin—Contusion—Prednisone—systemic scleroderma	0.00689	0.00689	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Leflunomide—systemic scleroderma	0.00687	0.00687	CcSEcCtD
Gonadorelin—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00673	0.00673	CcSEcCtD
Gonadorelin—Breast disorder—Lisinopril—systemic scleroderma	0.00664	0.00664	CcSEcCtD
Gonadorelin—Shock—Pentoxifylline—systemic scleroderma	0.00662	0.00662	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Mycophenolic acid—systemic scleroderma	0.00655	0.00655	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Lisinopril—systemic scleroderma	0.0059	0.0059	CcSEcCtD
Gonadorelin—Anaphylactic shock—Mometasone—systemic scleroderma	0.0058	0.0058	CcSEcCtD
Gonadorelin—Constipation—Pentoxifylline—systemic scleroderma	0.00575	0.00575	CcSEcCtD
Gonadorelin—Immune system disorder—Azathioprine—systemic scleroderma	0.00566	0.00566	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.0055	0.0055	CcSEcCtD
Gonadorelin—Immune system disorder—Leflunomide—systemic scleroderma	0.00534	0.00534	CcSEcCtD
Gonadorelin—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00532	0.00532	CcSEcCtD
Gonadorelin—Angiopathy—Mycophenolic acid—systemic scleroderma	0.00512	0.00512	CcSEcCtD
Gonadorelin—Anaphylactic shock—Captopril—systemic scleroderma	0.0051	0.0051	CcSEcCtD
Gonadorelin—Flatulence—Leflunomide—systemic scleroderma	0.00507	0.00507	CcSEcCtD
Gonadorelin—Shock—Captopril—systemic scleroderma	0.00502	0.00502	CcSEcCtD
Gonadorelin—Fatigue—Mometasone—systemic scleroderma	0.005	0.005	CcSEcCtD
Gonadorelin—Pain—Mometasone—systemic scleroderma	0.00496	0.00496	CcSEcCtD
Gonadorelin—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00496	0.00496	CcSEcCtD
Gonadorelin—Flatulence—Mycophenolic acid—systemic scleroderma	0.00484	0.00484	CcSEcCtD
Gonadorelin—Asthenia—Pentoxifylline—systemic scleroderma	0.00483	0.00483	CcSEcCtD
Gonadorelin—Pruritus—Pentoxifylline—systemic scleroderma	0.00476	0.00476	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00475	0.00475	CcSEcCtD
Gonadorelin—Angiopathy—Lisinopril—systemic scleroderma	0.00461	0.00461	CcSEcCtD
Gonadorelin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.0046	0.0046	CcSEcCtD
Gonadorelin—Abdominal pain—Mometasone—systemic scleroderma	0.00459	0.00459	CcSEcCtD
Gonadorelin—Erythema—Lisinopril—systemic scleroderma	0.00442	0.00442	CcSEcCtD
Gonadorelin—Fatigue—Captopril—systemic scleroderma	0.0044	0.0044	CcSEcCtD
Gonadorelin—Constipation—Captopril—systemic scleroderma	0.00436	0.00436	CcSEcCtD
Gonadorelin—Flatulence—Lisinopril—systemic scleroderma	0.00436	0.00436	CcSEcCtD
Gonadorelin—Vomiting—Pentoxifylline—systemic scleroderma	0.00428	0.00428	CcSEcCtD
Gonadorelin—Headache—Pentoxifylline—systemic scleroderma	0.00421	0.00421	CcSEcCtD
Gonadorelin—Anaphylactic shock—Leflunomide—systemic scleroderma	0.0042	0.0042	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Captopril—systemic scleroderma	0.00417	0.00417	CcSEcCtD
Gonadorelin—Asthenia—Mometasone—systemic scleroderma	0.00416	0.00416	CcSEcCtD
Gonadorelin—Nervous system disorder—Leflunomide—systemic scleroderma	0.00412	0.00412	CcSEcCtD
Gonadorelin—Pruritus—Mometasone—systemic scleroderma	0.00411	0.00411	CcSEcCtD
Gonadorelin—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00404	0.00404	CcSEcCtD
Gonadorelin—Abdominal pain—Captopril—systemic scleroderma	0.00403	0.00403	CcSEcCtD
Gonadorelin—Nausea—Pentoxifylline—systemic scleroderma	0.004	0.004	CcSEcCtD
Gonadorelin—Diarrhoea—Mometasone—systemic scleroderma	0.00397	0.00397	CcSEcCtD
Gonadorelin—Shock—Mycophenolic acid—systemic scleroderma	0.00394	0.00394	CcSEcCtD
Gonadorelin—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00393	0.00393	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00384	0.00384	CcSEcCtD
Gonadorelin—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Gonadorelin—Vomiting—Mometasone—systemic scleroderma	0.00369	0.00369	CcSEcCtD
Gonadorelin—Asthenia—Captopril—systemic scleroderma	0.00366	0.00366	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00364	0.00364	CcSEcCtD
Gonadorelin—Headache—Mometasone—systemic scleroderma	0.00364	0.00364	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Gonadorelin—Fatigue—Leflunomide—systemic scleroderma	0.00362	0.00362	CcSEcCtD
Gonadorelin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00361	0.00361	CcSEcCtD
Gonadorelin—Pruritus—Captopril—systemic scleroderma	0.00361	0.00361	CcSEcCtD
Gonadorelin—Constipation—Leflunomide—systemic scleroderma	0.00359	0.00359	CcSEcCtD
Gonadorelin—Pain—Leflunomide—systemic scleroderma	0.00359	0.00359	CcSEcCtD
Gonadorelin—Shock—Lisinopril—systemic scleroderma	0.00355	0.00355	CcSEcCtD
Gonadorelin—Abdominal pain—Azathioprine—systemic scleroderma	0.00352	0.00352	CcSEcCtD
Gonadorelin—Diarrhoea—Captopril—systemic scleroderma	0.00349	0.00349	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00346	0.00346	CcSEcCtD
Gonadorelin—Fatigue—Mycophenolic acid—systemic scleroderma	0.00346	0.00346	CcSEcCtD
Gonadorelin—Nausea—Mometasone—systemic scleroderma	0.00345	0.00345	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00344	0.00344	CcSEcCtD
Gonadorelin—Constipation—Mycophenolic acid—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Gonadorelin—Pain—Mycophenolic acid—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Gonadorelin—Abdominal pain—Leflunomide—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Gonadorelin—Breast disorder—Methotrexate—systemic scleroderma	0.00329	0.00329	CcSEcCtD
Gonadorelin—Hypersensitivity—Azathioprine—systemic scleroderma	0.00328	0.00328	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00328	0.00328	CcSEcCtD
Gonadorelin—Vomiting—Captopril—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Gonadorelin—Headache—Captopril—systemic scleroderma	0.00319	0.00319	CcSEcCtD
Gonadorelin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Gonadorelin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00312	0.00312	CcSEcCtD
Gonadorelin—Fatigue—Lisinopril—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Gonadorelin—Shock—Mycophenolate mofetil—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Gonadorelin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.0031	0.0031	CcSEcCtD
Gonadorelin—Hypersensitivity—Leflunomide—systemic scleroderma	0.0031	0.0031	CcSEcCtD
Gonadorelin—Constipation—Lisinopril—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Gonadorelin—Pain—Lisinopril—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Gonadorelin—Diarrhoea—Azathioprine—systemic scleroderma	0.00304	0.00304	CcSEcCtD
Gonadorelin—Nausea—Captopril—systemic scleroderma	0.00303	0.00303	CcSEcCtD
Gonadorelin—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Gonadorelin—Asthenia—Leflunomide—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Gonadorelin—Pruritus—Leflunomide—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00295	0.00295	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.00293	0.00293	CcSEcCtD
Gonadorelin—Asthenia—Mycophenolic acid—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Gonadorelin—Diarrhoea—Leflunomide—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Gonadorelin—Abdominal pain—Lisinopril—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Gonadorelin—Pruritus—Mycophenolic acid—systemic scleroderma	0.00284	0.00284	CcSEcCtD
Gonadorelin—Vomiting—Azathioprine—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Gonadorelin—Headache—Azathioprine—systemic scleroderma	0.00279	0.00279	CcSEcCtD
Gonadorelin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Gonadorelin—Angiopathy—Prednisone—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Gonadorelin—Immune system disorder—Prednisone—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Gonadorelin—Pain—Mycophenolate mofetil—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Gonadorelin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Gonadorelin—Vomiting—Leflunomide—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Gonadorelin—Hypersensitivity—Lisinopril—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Gonadorelin—Nausea—Azathioprine—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Gonadorelin—Headache—Leflunomide—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Gonadorelin—Erythema—Prednisone—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Gonadorelin—Asthenia—Lisinopril—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Gonadorelin—Pruritus—Lisinopril—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Gonadorelin—Vomiting—Mycophenolic acid—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Gonadorelin—Headache—Mycophenolic acid—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Gonadorelin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Gonadorelin—Nausea—Leflunomide—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Gonadorelin—Diarrhoea—Lisinopril—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Gonadorelin—Nausea—Mycophenolic acid—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Gonadorelin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Gonadorelin—Vomiting—Lisinopril—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Gonadorelin—Angiopathy—Methotrexate—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Gonadorelin—Immune system disorder—Methotrexate—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Gonadorelin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Gonadorelin—Headache—Lisinopril—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Gonadorelin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Gonadorelin—Erythema—Methotrexate—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Gonadorelin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Gonadorelin—Nausea—Lisinopril—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Gonadorelin—Anaphylactic shock—Prednisone—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Gonadorelin—Shock—Prednisone—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Gonadorelin—Nervous system disorder—Prednisone—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Gonadorelin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Gonadorelin—Headache—Mycophenolate mofetil—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Gonadorelin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Gonadorelin—Fatigue—Prednisone—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Gonadorelin—Constipation—Prednisone—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Gonadorelin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Gonadorelin—Nervous system disorder—Methotrexate—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Gonadorelin—Abdominal pain—Prednisone—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Gonadorelin—Hypersensitivity—Prednisone—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Gonadorelin—Fatigue—Methotrexate—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Gonadorelin—Asthenia—Prednisone—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Gonadorelin—Pain—Methotrexate—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Gonadorelin—Pruritus—Prednisone—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Gonadorelin—Diarrhoea—Prednisone—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Gonadorelin—Abdominal pain—Methotrexate—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Gonadorelin—Vomiting—Prednisone—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Gonadorelin—Headache—Prednisone—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Gonadorelin—Hypersensitivity—Methotrexate—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Gonadorelin—Asthenia—Methotrexate—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Gonadorelin—Nausea—Prednisone—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Gonadorelin—Pruritus—Methotrexate—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Gonadorelin—Diarrhoea—Methotrexate—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Gonadorelin—Vomiting—Methotrexate—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Gonadorelin—Headache—Methotrexate—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Gonadorelin—Nausea—Methotrexate—systemic scleroderma	0.00106	0.00106	CcSEcCtD
